Robert M Johnson
6PUBLICATIONS
133CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.James Logue, Robert M Johnson, Nita Patel
|Aug 12, 2022
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19.James Logue, Arup R Chakraborty, Robert Johnson
|May 26, 2022
Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.Bennett J Davenport, Alexis Catala, Stuart M Weston
|Apr 01, 2022
Defining the risk of SARS-CoV-2 variants on immune protection.Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman
|Feb 07, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2.David C Schultz, Robert M Johnson, Kasirajan Ayyanathan
|Nov 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara
Pageof 1
Frequent Collaborators
6 joint publications
Matthew B Frieman
4 joint publications
Stuart Weston
3 joint publications
James P Logue
3 joint publications
Marisa E McGrath
2 joint publications
Dan H Barouch
2 joint publications
Robert E Haupt
1 joint publications
Louis J Taylor
1 joint publications
Gale Smith
1 joint publications
Viktor Horvath
1 joint publications
Donald E Ingber
